+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Immune Pharmaceuticals - logo

Immune Pharmaceuticals is a clinical stage biopharmaceutical company that develops novel targeted therapeutics in the immuno-inflammation and immuno-oncology areas. The company's lead product candidate is Bertilimumab, a human monoclonal antibody, which is in Phase II clinical trial for the treatment of ulcerative colitis, bullous pemphigoid, and Crohn's disease. Immune Pharmaceuticals, Inc. was founded in 2010 and is headquartered in New York, New York.

US Transdermal Patch Market Outlook 2020 - Product Thumbnail Image

US Transdermal Patch Market Outlook 2020

  • Report
  • July 2016
  • 370 Pages
From
From
From
From
BCMA Targeted Therapies, 2017-2030 - Product Thumbnail Image

BCMA Targeted Therapies, 2017-2030

  • Report
  • March 2017
  • 143 Pages
From
From
Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2020 - Product Thumbnail Image

Kidney Cancer (Renal Cell Cancer) - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 2815 pages
From
From
From
NASH Drugs Market, 2015 - 2025 - Product Thumbnail Image

NASH Drugs Market, 2015 - 2025

  • Report
  • September 2015
  • 188 Pages
From
From
From
Chronic Myelomonocytic Leukaemia - Pipeline Insight, 2021 - Product Thumbnail Image

Chronic Myelomonocytic Leukaemia - Pipeline Insight, 2021

  • Clinical Trials
  • May 2021
  • 60 pages
From
From
From
From
From
From
Loading Indicator
adroll